BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 12128285)

  • 1. Prolactin as an autocrine/paracrine growth factor in human cancer.
    Ben-Jonathan N; Liby K; McFarland M; Zinger M
    Trends Endocrinol Metab; 2002 Aug; 13(6):245-50. PubMed ID: 12128285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin involvement in breast cancer.
    Vonderhaar BK
    Endocr Relat Cancer; 1999 Sep; 6(3):389-404. PubMed ID: 10516853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice.
    Bole-Feysot C; Goffin V; Edery M; Binart N; Kelly PA
    Endocr Rev; 1998 Jun; 19(3):225-68. PubMed ID: 9626554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin as an autocrine/paracrine factor in breast tissue.
    Clevenger CV; Plank TL
    J Mammary Gland Biol Neoplasia; 1997 Jan; 2(1):59-68. PubMed ID: 10887520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autocrine/paracrine roles of extrapituitary growth hormone and prolactin in health and disease: An overview.
    Harvey S; Martínez-Moreno CG; Luna M; Arámburo C
    Gen Comp Endocrinol; 2015 Sep; 220():103-11. PubMed ID: 25448258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of prolactin in mammary carcinoma.
    Clevenger CV; Furth PA; Hankinson SE; Schuler LA
    Endocr Rev; 2003 Feb; 24(1):1-27. PubMed ID: 12588805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should prolactin be reconsidered as a therapeutic target in human breast cancer?
    Goffin V; Touraine P; Pichard C; Bernichtein S; Kelly PA
    Mol Cell Endocrinol; 1999 May; 151(1-2):79-87. PubMed ID: 10411322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New concepts in prolactin biology.
    Bernichtein S; Touraine P; Goffin V
    J Endocrinol; 2010 Jul; 206(1):1-11. PubMed ID: 20371569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammary gland development and the prolactin receptor.
    Binart N; Ormandy CJ; Kelly PA
    Adv Exp Med Biol; 2000; 480():85-92. PubMed ID: 10959413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What can we learn from rodents about prolactin in humans?
    Ben-Jonathan N; LaPensee CR; LaPensee EW
    Endocr Rev; 2008 Feb; 29(1):1-41. PubMed ID: 18057139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin overexpression by MDA-MB-435 human breast cancer cells accelerates tumor growth.
    Liby K; Neltner B; Mohamet L; Menchen L; Ben-Jonathan N
    Breast Cancer Res Treat; 2003 May; 79(2):241-52. PubMed ID: 12825859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin receptor antagonists.
    Kuo CB; Coss D; Walker AM
    Endocrine; 1998 Oct; 9(2):121-31. PubMed ID: 9867245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin: the new biology of an old hormone.
    Goffin V; Binart N; Touraine P; Kelly PA
    Annu Rev Physiol; 2002; 64():47-67. PubMed ID: 11826263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin-induced prostate tumorigenesis.
    Sackmann-Sala L; Goffin V
    Adv Exp Med Biol; 2015; 846():221-42. PubMed ID: 25472541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin is an autocrine or paracrine growth factor for human myometrial and leiomyoma cells.
    Nowak RA; Mora S; Diehl T; Rhoades AR; Stewart EA
    Gynecol Obstet Invest; 1999; 48(2):127-32. PubMed ID: 10461005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of prolactin in breast cancer: redefining the molecular targets.
    Llovera M; Touraine P; Kelly PA; Goffin V
    Exp Gerontol; 2000 Feb; 35(1):41-51. PubMed ID: 10705038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of prolactin receptor antagonist to better understand prolactin regulation of pituitary homeostasis.
    Ferraris J; Bernichtein S; Pisera D; Goffin V
    Neuroendocrinology; 2013; 98(3):171-9. PubMed ID: 23969780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway.
    Dagvadorj A; Collins S; Jomain JB; Abdulghani J; Karras J; Zellweger T; Li H; Nurmi M; Alanen K; Mirtti T; Visakorpi T; Bubendorf L; Goffin V; Nevalainen MT
    Endocrinology; 2007 Jul; 148(7):3089-101. PubMed ID: 17412813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autocrine actions of prolactin contribute to the regulation of lactotroph function in vivo.
    Bernard V; Lamothe S; Beau I; Guillou A; Martin A; Le Tissier P; Grattan D; Young J; Binart N
    FASEB J; 2018 Sep; 32(9):4791-4797. PubMed ID: 29596024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine, paracrine and autocrine actions of prolactin on immune cells.
    Matera L
    Life Sci; 1996; 59(8):599-614. PubMed ID: 8761011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.